Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcom (Q45747974)
Jump to navigation
Jump to search
scientific article published in September 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcom |
scientific article published in September 1999 |
Statements
1 reference
Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcom (English)
1 reference
1 reference
1 reference
Feinberg JE
1 reference
Grywacz M
1 reference
Knight S
1 reference
Griffiths PD
1 reference
1 September 1999
1 reference
1 reference
180
1 reference
3
1 reference
695-701
1 reference
Identifiers
1 reference
1 reference